Supporting SMEs to advance their solutions in the fight against COVID-19
The 2-year COVID-X (COVID eXponential Programme) project will jump-start over 30 European solutions onto the market, providing: 1) Up to EUR 150 000 in equity-free funding to companies to validate their initiatives in real-world healthcare sites; 2) A 10-month acceleration programme to consolidate the ideas, including technical support, ethical validation and business coaching; 3) Exclusive access to the COVID-X SandBox, the one-stop platform for exploiting COVID-19 data sources for management, integration and visualisation. The first COVID-X Open Call closed in January 2021, receiving 112 applications from 29 countries. Following evaluations, the top 10 solutions with TRL7+ will be supported to begin advancing their solutions in the areas of diagnosis, prognosis and follow-up. The second COVID-X Open Call is due to take place before summer 2021. For more information, please see: covid-x.eu “COVID-X is working to ensure that the selected projects will deliver concrete solutions to fight the pandemic by the end of the acceleration programme. We are confident that the project we’ll be supporting through the acceleration programme will help save lives and contribute to a more resilient society.” – Antonio Damasceno, COVID-X project coordinator If you are interested in having your project featured in ‘Project of the Month’ in an upcoming issue, please send us an email to editorial@cordis.europa.eu and tell us why!
Keywords
COVID-X, SMEs, COVID-19, healthcare, data technology, acceleration programme, business coaching, TRL, coronavirus